Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 87 articles:
HTML format



Single Articles


    March 2021
  1. FAN HM, Mitchell AL, Williamson C
    ENDOCRINOLOGY IN PREGNANCY: Metabolic impact of bile acids in gestation.
    Eur J Endocrinol. 2021;184:R69-R83.
    PubMed     Abstract available


  2. FERREIRA JP, Oliveira AC, Saraiva FA, Vasques-Novoa F, et al
    Sodium-glucose co-transporter inhibitors in insulin-treated diabetes: a meta-analysis.
    Eur J Endocrinol. 2021 Mar 1. pii: EJE-20-1484.R2. doi: 10.1530/EJE-20-1484.
    PubMed     Abstract available


    February 2021
  3. BONFANTI R, Iafusco D, Rabbone I, Diedenhofen G, et al
    Differences between Transient Neonatal Diabetes Mellitus Subtypes can Guide Diagnosis and Therapy.
    Eur J Endocrinol. 2021 Feb 1. pii: EJE-20-1030.R1. doi: 10.1530/EJE-20-1030.
    PubMed     Abstract available


  4. JULIAN MT, Pera G, Soldevila B, Caballeria L, et al
    Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: A population -based study.
    Eur J Endocrinol. 2021 Feb 1. pii: EJE-20-1240.R1. doi: 10.1530/EJE-20-1240.
    PubMed     Abstract available


  5. BEHANOVA M, Haschka J, Zwerina J, Wascher TC, et al
    The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortality.
    Eur J Endocrinol. 2021 Feb 1. pii: EJE-20-1155.R1. doi: 10.1530/EJE-20-1155.
    PubMed     Abstract available


    January 2021
  6. DALSGAARD NB, Gasbjerg LS, Hansen LS, Hansen NL, et al
    The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes.
    Eur J Endocrinol. 2021 Jan 1. pii: EJE-20-1121.R1. doi: 10.1530/EJE-20-1121.
    PubMed     Abstract available


  7. FALLAHI P, Ferrari SM, Elia G, Ragusa F, et al
    THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors.
    Eur J Endocrinol. 2021;184:R29-R40.
    PubMed     Abstract available


  8. PETROV MS, Basina M
    diagnosis of endocrine disease: Diagnosing and classifying diabetes in diseases of the exocrine pancreas.
    Eur J Endocrinol. 2021 Jan 1. pii: EJE-20-0974.R1. doi: 10.1530/EJE-20-0974.
    PubMed     Abstract available


  9. PETROV MS
    diagnosis of endocrine disease: POST-PANCREATITIS DIABETES MELLITUS: PRIME TIME FOR SECONDARY DISEASE.
    Eur J Endocrinol. 2021 Jan 1. pii: EJE-20-0468.R3. doi: 10.1530/EJE-20-0468.
    PubMed     Abstract available


  10. LYTRIVI M, Senee V, Salpea P, Fantuzzi F, et al
    DNAJC3 deficiency induces beta-cell mitochondrial apoptosis and causes syndromic young-onset diabetes.
    Eur J Endocrinol. 2021 Jan 1. pii: EJE-20-0636.R2. doi: 10.1530/EJE-20-0636.
    PubMed     Abstract available


    December 2020
  11. LAPAUW B, Kaufman JM
    MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Eur J Endocrinol. 2020;183:R167-R183.
    PubMed     Abstract available


  12. MOSORIN ME, Haverinen A, Ollila MM, Nordstrom T, et al
    Current use of combined hormonal contraception is associated with glucose metabolism disorders in perimenopausal women.
    Eur J Endocrinol. 2020;183:619-626.
    PubMed     Abstract available


  13. TSENG CH
    Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus.
    Eur J Endocrinol. 2020 Dec 1. pii: EJE-20-0507.R2. doi: 10.1530/EJE-20-0507.
    PubMed     Abstract available


  14. DEVUYST F, Kazakou P, Baleriaux D, Alexopoulou O, et al
    Pituitary stalk thickening: neoplastic or not? - author's response to the letter by Wang et al.
    Eur J Endocrinol. 2020;183:L23-L25.
    PubMed    


    November 2020
  15. CHAE HW, Na JH, Kim HS, Lee YM, et al
    Mitochondrial diabetes and mitochondrial DNA mutation load in MELAS syndrome.
    Eur J Endocrinol. 2020;183:505-512.
    PubMed     Abstract available


    October 2020
  16. SJOSTROM A, Bartuseviciene I, Hoybye C
    Simplified and improved fluid deprivation test for diagnosing diabetes insipidus.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0759.R2. doi: 10.1530/EJE-20-0759.
    PubMed     Abstract available


  17. SUBRAMANIAN A, Idkowiak J, Toulis KA, Thangaratinam S, et al
    Pubertal timing in boys and girls born to mothers with gestational diabetes mellitus: a systematic review.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0296.R2. doi: 10.1530/EJE-20-0296.
    PubMed     Abstract available


    September 2020
  18. OVERGAARD M, Glintborg D, Christesen HT, Jensen TK, et al
    Maternal prolactin is associated with glucose status and PCOS in pregnancy: Odense Child Cohort.
    Eur J Endocrinol. 2020;183:307-316.
    PubMed     Abstract available


    August 2020
  19. BICHET DG
    GENETICS IN ENDOCRINOLOGY Pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus.
    Eur J Endocrinol. 2020;183:R29-R40.
    PubMed     Abstract available


    July 2020
  20. DEVUYST F, Kazakou P, Baleriaux D, Alexopoulou O, et al
    Central diabetes insipidus and pituitary stalk thickening in adults: distinction of neoplastic from non-neoplastic lesions.
    Eur J Endocrinol. 2020;181:95-105.
    PubMed     Abstract available


    June 2020
  21. WAKE DJ, Gibb FW, Kar P, Kennon B, et al
    Endocrinology in the time of COVID-19: Remodelling Diabetes Services and Promoting Innovation.
    Eur J Endocrinol. 2020 Jun 5. pii: EJE-20-0377.R1. doi: 10.1530/EJE-20-0377.
    PubMed     Abstract available


  22. CUNHA-GUIMARAES JP, Guarino MP, Timoteo AT, Caires I, et al
    Carotid body chemosensitivity: early biomarker of dysmetabolism in humans.
    Eur J Endocrinol. 2020;182:549-557.
    PubMed     Abstract available


  23. WANG S, Zhang Y, Lei S, Zhu H, et al
    Performance of deep neural network-based artificial intelligence method in diabetic retinopathy screening: a systematic review and meta-analysis of diagnostic test accuracy.
    Eur J Endocrinol. 2020;183:41-49.
    PubMed     Abstract available


  24. FERREIRA JP, Lamiral Z, Xhaard C, Duarte K, et al
    Circulating plasma proteins and new-onset diabetes in a population-based study: proteomic and genomic insights from the STANISLAS cohort.
    Eur J Endocrinol. 2020 Jun 1. pii: EJE-20-0246.R2. doi: 10.1530/EJE-20-0246.
    PubMed     Abstract available


    May 2020
  25. THANGARATINAM S, Cooray SD, Sukumar N, Huda MS, et al
    Endocrinology in the time of COVID-19: Diagnosis and Management of Gestational Diabetes Mellitus.
    Eur J Endocrinol. 2020 May 1. pii: EJE-20-0401.R1. doi: 10.1530/EJE-20-0401.
    PubMed     Abstract available


    April 2020
  26. CHANTZICHRISTOS D, Eliasson B, Johannsson G
    MANAGEMENT OF ENDOCRINE DISEASE: Disease burden and treatment challenges in patients with both Addison's disease and type 1 diabetes mellitus.
    Eur J Endocrinol. 2020 Apr 1. pii: EJE-20-0052.R2. doi: 10.1530/EJE-20-0052.
    PubMed     Abstract available


  27. CHRIST CRAIN M, Hoorn EJ, Sherlock M, Thompson CJ, et al
    Endocrinology in the time of COVID-19: Management of Hyponatraemia and Diabetes Insipidus.
    Eur J Endocrinol. 2020 Apr 1. pii: EJE-20-0338. doi: 10.1530/EJE-20-0338.
    PubMed     Abstract available


    March 2020
  28. FUCHTBAUER L, Olsson DS, Coopmans EC, Bengtsson BA, et al
    Increased number of retinal vessels in acromegaly.
    Eur J Endocrinol. 2020;182:293-302.
    PubMed     Abstract available


  29. RORTH R, Jorgensen PG, Andersen HU, Christoffersen C, et al
    Cardiovascular prognostic value of echocardiography and N terminal pro B-type natriuretic peptide in type 1 diabetes: The Thousand and 1 Study.
    Eur J Endocrinol. 2020 Mar 1. pii: EJE-19-1015.R1. doi: 10.1530/EJE-19-1015.
    PubMed     Abstract available


    February 2020
  30. STOMBY A, Otten J, Ryberg M, Andrew R, et al
    Diet-induced weight loss alters hepatic glucocorticoid metabolism in type 2 diabetes mellitus.
    Eur J Endocrinol. 2020 Feb 1. pii: EJE-19-0901.R1. doi: 10.1530/EJE-19-0901.
    PubMed     Abstract available


  31. PEK S, Lim SC, Ang K, Kwan PY, et al
    Endothelin-1 predicts incident Diabetic Peripheral Neuropathy in Type 2 Diabetes: A cohort study.
    Eur J Endocrinol. 2020 Feb 1. pii: EJE-19-0523.R2. doi: 10.1530/EJE-19-0523.
    PubMed     Abstract available


    December 2019
  32. JENSEN NJ, Nilsson M, Ingerslev JS, Olsen DA, et al
    Effects of beta-hydroxybutyrate on cognition in patients with type 2 diabetes.
    Eur J Endocrinol. 2019 Dec 1. pii: EJE-19-0710.R1. doi: 10.1530/EJE-19-0710.
    PubMed     Abstract available


    November 2019
  33. VALASSI E, Tabarin A, Brue T, Feelders RA, et al
    High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registry.
    Eur J Endocrinol. 2019;181:461-472.
    PubMed     Abstract available


    October 2019
  34. JIANG J, Liu X, Liu X, Tian Z, et al
    The effect of progesterone and pregnenolone on diabetes status in Chinese rural population: a dose-response analysis from Henan Rural Cohort.
    Eur J Endocrinol. 2019 Oct 1. pii: EJE-19-0352.R2. doi: 10.1530/EJE-19-0352.
    PubMed     Abstract available


  35. NAUCK MA, Meier JJ
    MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonist equal in the treatment of type 2 diabetes?
    Eur J Endocrinol. 2019 Oct 1. pii: EJE-19-0566.R1. doi: 10.1530/EJE-19-0566.
    PubMed     Abstract available


  36. DHINDSA S, Ghanim H, Green K, Abuaysheh S, et al
    Acute effects of insulin on skeletal muscle growth and differentiation genes in men with type 2 diabetes.
    Eur J Endocrinol. 2019 Oct 1. pii: EJE-19-0514.R1. doi: 10.1530/EJE-19-0514.
    PubMed     Abstract available


  37. MAXWELL JD, Carter HH, Hellsten Y, Miller GD, et al
    Seven day remote ischaemic preconditioning improves endothelial function in patients with type 2 diabetes mellitus: a randomised pilot study.
    Eur J Endocrinol. 2019 Oct 1. pii: EJE-19-0378.R1. doi: 10.1530/EJE-19-0378.
    PubMed     Abstract available


  38. KAMPMANN FB, Thuesen ACB, Hjort L, Bjerregaard AA, et al
    Increased leptin, decreased adiponectin and FGF21 concentrations in adolescent offspring of women with gestational diabetes.
    Eur J Endocrinol. 2019 Oct 1. pii: EJE-19-0658.R1. doi: 10.1530/EJE-19-0658.
    PubMed     Abstract available


    September 2019
  39. KO SH, Han K, Yun JS, Chung S, et al
    Impact of obesity and diabetes on the incidence of kidney and bladder cancers: a nationwide cohort study.
    Eur J Endocrinol. 2019 Sep 1. pii: EJE-19-0500.R2. doi: 10.1530/EJE-19-0500.
    PubMed     Abstract available


  40. YOFFE L, Polsky A, Gilam A, Raff C, et al
    Early Diagnosis of Gestational Diabetes Mellitus Using Circulating MicroRNAs.
    Eur J Endocrinol. 2019 Sep 1. pii: EJE-19-0206.R2. doi: 10.1530/EJE-19-0206.
    PubMed     Abstract available


  41. LEMIEUX P, Weisnagel SJ, Caron AZ, Julien AS, et al
    Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial.
    Eur J Endocrinol. 2019;181:287-299.
    PubMed     Abstract available


    August 2019
  42. DIAMANTI-KANDARAKIS E, Duntas L, Kanakis GA, Kandaraki E, et al
    DIAGNOSIS OF ENDOCRINE DISEASE: Drug-induced endocrinopathies and diabetes: a combo-endocrinology overview.
    Eur J Endocrinol. 2019;181:R73-R105.
    PubMed     Abstract available


  43. CORICA D, Zusi C, Olivieri F, Marigliano M, et al
    Vitamin D affects insulin sensitivity and beta-cell function in obese non-diabetic youths.
    Eur J Endocrinol. 2019 Aug 1. pii: EJE-19-0369.R1. doi: 10.1530/EJE-19-0369.
    PubMed     Abstract available


  44. WIUM-ANDERSEN IK, Osler M, Jorgensen MB, Rungby J, et al
    Antidiabetic medication and risk of dementia in patients with type 2 diabetes. A nested case-control study.
    Eur J Endocrinol. 2019 Aug 1. pii: EJE-19-0259.R1. doi: 10.1530/EJE-19-0259.
    PubMed     Abstract available


    July 2019
  45. DE FILETTE JMK, Pen JJ, Decoster L, Vissers T, et al
    Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review.
    Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0291.R1. doi: 10.1530/EJE-19-0291.
    PubMed     Abstract available


  46. CHRIST-CRAIN M
    EJE AWARD 2019: New diagnostic approaches for patients with polyuria polydipsia syndrome.
    Eur J Endocrinol. 2019;181:R11-R21.
    PubMed     Abstract available


    June 2019
  47. BENHALIMA K, Van Crombrugge P, Moyson C, Verhaeghe J, et al
    Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria
    Eur J Endocrinol. 2019;180:353-363.
    PubMed     Abstract available


  48. HYGUM K, Starup-Linde JK, Harslof T, Joergensen NR, et al
    The diurnal variation of bone formation is attenuated in adult patients with type 2 diabetes.
    Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0309.R1. doi: 10.1530/EJE-19-0309.
    PubMed     Abstract available


  49. SINN DH, Kang D, Cho SJ, Paik SW, et al
    Lean non-alcoholic fatty liver disease and development of diabetes: A cohort study.
    Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0143.R1. doi: 10.1530/EJE-19-0143.
    PubMed     Abstract available


  50. PATTI G, Scianguetta S, Roberti D, Di Mascio A, et al
    Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene.
    Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0299.R2. doi: 10.1530/EJE-19-0299.
    PubMed     Abstract available


    May 2019
  51. PRINZ N, Konrad K, Brack C, Hahn E, et al
    Diabetes care in pediatric refugees from Africa or Middle East - experiences from Germany and Austria based on real-world data from the DPV registry.
    Eur J Endocrinol. 2019 May 1. pii: EJE-18-0898.R2. doi: 10.1530/EJE-18-0898.
    PubMed     Abstract available


    April 2019
  52. FAGHERAZZI G, Gusto G, El Fatouhi D, Mancini FR, et al
    Mentally tiring work and type 2 diabetes in women: a 22-year follow-up study.
    Eur J Endocrinol. 2019;180:257-263.
    PubMed     Abstract available


  53. TSENG CH
    Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
    Eur J Endocrinol. 2019 Apr 1. pii: EJE-19-0133.R1. doi: 10.1530/EJE-19-0133.
    PubMed     Abstract available


    March 2019
  54. VALDES S, Doulatram Gamgaram VK, Lago A, Garcia-Torres F, et al
    Ambient temperature and prevalence of diabetes and insulin resistance in the Spanish population. Di@bet.es study.
    Eur J Endocrinol. 2019 Mar 1. pii: EJE-18-0818.R2. doi: 10.1530/EJE-18-0818.
    PubMed     Abstract available


    February 2019
  55. ALMEDA-VALDES P, Gomez Velasco DV, Arellano Campos O, Bello-Chavolla OY, et al
    The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes.
    Eur J Endocrinol. 2019;180:99-107.
    PubMed     Abstract available


    January 2019
  56. XU G, You D, Wong L, Duan D, et al
    Risk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysis.
    Eur J Endocrinol. 2019 Jan 1. pii: EJE-18-0792.R1. doi: 10.1530/EJE-18-0792.
    PubMed     Abstract available


    December 2018
  57. NEDERSTIGT C, Uitbeijerse B, Janssen L, Corssmit EP, et al
    Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis.
    Eur J Endocrinol. 2018 Dec 1. pii: EJE-18-0515.R1. doi: 10.1530/EJE-18-0515.
    PubMed     Abstract available


  58. EJTAHED HS, Tito RY, Siadat SD, Hasani-Ranjbar S, et al
    Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial.
    Eur J Endocrinol. 2018 Dec 1. pii: EJE-18-0826.R1. doi: 10.1530/EJE-18-0826.
    PubMed     Abstract available


    October 2018
  59. NISKANEN L, Partonen T, Auvinen A, Haukka J, et al
    Excess mortality in Finnish diabetic subjects due to alcohol, accidents and suicide: a nationwide study
    Eur J Endocrinol. 2018;179:299-306.
    PubMed     Abstract available


  60. NORDHEIM E, Birkeland KI, Asberg A, Hartmann A, et al
    Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study
    Eur J Endocrinol. 2018;179:251-259.
    PubMed     Abstract available


  61. HAMMARSTRAND C, Ragnarsson O, Bengtsson O, Bryngelsson IL, et al
    Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement
    Eur J Endocrinol. 2018;179:229-237.
    PubMed     Abstract available


  62. NTOUVA A, Toulis KA, Keerthy D, Adderley NJ, et al
    Hypoglycaemia is associated with increased risk of fractures in patients with type 2 diabetes mellitus: a cohort study.
    Eur J Endocrinol. 2018 Oct 1. pii: EJE-18-0458.R2. doi: 10.1530/EJE-18-0458.
    PubMed     Abstract available


  63. ANAGNOSTIS P, Christou K, Artzouchaltzi AM, Gkekas NK, et al
    Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis.
    Eur J Endocrinol. 2018 Oct 1. pii: EJE-18-0602.R1. doi: 10.1530/EJE-18-0602.
    PubMed     Abstract available


    August 2018
  64. OSSWALD A, Deutschbein T, Berr CM, Plomer E, et al
    Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Eur J Endocrinol. 2018;179:109-116.
    PubMed     Abstract available


  65. BILLETER AT, de la Garza Herrera JR, Scheurlen KM, Nickel F, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass.
    Eur J Endocrinol. 2018;179:R77-R93.
    PubMed     Abstract available


  66. MICHAEL BESSER G, Pfeiffer RF, Thorner MO
    ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine.
    Eur J Endocrinol. 2018;179:R69-R75.
    PubMed     Abstract available


    July 2018
  67. MENDOZA LC, Harreiter J, Simmons D, Desoye G, et al
    Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point.
    Eur J Endocrinol. 2018;179:39-49.
    PubMed     Abstract available


    June 2018
  68. ANDERSEN MS, Glintborg D
    Diagnosis and follow-up of type 2 diabetes in women with PCOS. A role of OGTT?
    Eur J Endocrinol. 2018 Jun 19. pii: EJE-18-0237. doi: 10.1530/EJE-18-0237.
    PubMed     Abstract available


  69. KNOP FK
    EJE PRIZE 2018: A gut feeling about glucagon.
    Eur J Endocrinol. 2018;178:R267-R280.
    PubMed     Abstract available


    May 2018
  70. SHEN Y, Wang P, Wang L, Zhang S, et al
    Gestational diabetes with diabetes and prediabetes risks: A large observational study.
    Eur J Endocrinol. 2018 May 9. pii: EJE-18-0130. doi: 10.1530/EJE-18-0130.
    PubMed     Abstract available


  71. HONKA MJ, Latva-Rasku A, Bucci M, Virtanen KA, et al
    Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study.
    Eur J Endocrinol. 2018;178:523-531.
    PubMed     Abstract available


    April 2018
  72. DI CAMILLO B, Hakaste L, Sambo F, Gabriel R, et al
    HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability.
    Eur J Endocrinol. 2018;178:331-341.
    PubMed     Abstract available


  73. ESTERLINE RL, Vaag A, Oscarsson J, Vora J, et al
    MECHANISMS IN ENDOCRINOLOGY: SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism?
    Eur J Endocrinol. 2018;178:R113-R125.
    PubMed     Abstract available


    March 2018
  74. WHICHER C, Price HC, Holt RI
    Antipsychotic Medication and Type 2 Diabetes and Impaired Glucose Regulation.
    Eur J Endocrinol. 2018 Mar 20. pii: EJE-18-0022. doi: 10.1530/EJE-18-0022.
    PubMed     Abstract available


  75. RYS P, Ludwig-Slomczynska AH, Cyganek K, Malecki MT, et al
    Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes mellitus - a systematic review and meta-analysis of randomised controlled trials and observational studies.
    Eur J Endocrinol. 2018 Mar 15. pii: EJE-17-0804. doi: 10.1530/EJE-17-0804.
    PubMed     Abstract available


  76. BELLO-CHAVOLLA OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, et al
    METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.
    Eur J Endocrinol. 2018 Mar 13. pii: EJE-17-0883. doi: 10.1530/EJE-17-0883.
    PubMed     Abstract available


  77. PARK SK, Ryoo JH, Oh CM, Choi JM, et al
    Longitudinally evaluated the relationship between body fat percentage and the risk for type 2 diabetes mellitus: Korean Genome and Epidemiology Study (KoGES).
    Eur J Endocrinol. 2018 Mar 9. pii: EJE-17-0868. doi: 10.1530/EJE-17-0868.
    PubMed     Abstract available


    February 2018
  78. LEVELT E, Gulsin GS, Neubauer S, McCann GP, et al
    MECHANISMS IN ENDOCRINOLOGY: Diabetic Cardiomyopathy - Pathophysiology and Potential Metabolic Interventions.
    Eur J Endocrinol. 2018 Feb 12. pii: EJE-17-0724. doi: 10.1530/EJE-17-0724.
    PubMed     Abstract available


  79. SUJANA C, Huth C, Zierer A, Meesters S, et al
    Association of fetuin-A with incident type 2 diabetes: Results from the MONICA/KORA Augsburg study and a systematic meta-analysis.
    Eur J Endocrinol. 2018 Feb 8. pii: EJE-17-1053. doi: 10.1530/EJE-17-1053.
    PubMed     Abstract available


  80. JENSEN RB, Thankamony A, Holst KK, Janssen JAMJL, et al
    Genetic influence on the associations between IGF-I and glucose metabolism in a cohort of elderly twins.
    Eur J Endocrinol. 2018;178:155-163.
    PubMed     Abstract available


  81. SCOTT ES, Long GV, Guminski A, Clifton-Bligh RJ, et al
    The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.
    Eur J Endocrinol. 2018;178:175-182.
    PubMed     Abstract available


    January 2018
  82. VASILEIOU V, Kyratzoglou E, Paschou SA, Kyprianou M, et al
    The impact of environmental temperature on the diagnosis of gestational diabetes mellitus.
    Eur J Endocrinol. 2018 Jan 23. pii: EJE-17-0730. doi: 10.1530/EJE-17-0730.
    PubMed     Abstract available


  83. GHANIM H, Dhindsa S, Abuaysheh S, Batra M, et al
    Diminished Androgen and Estrogen Receptors and Aromatase Levels in Hypogonadal Diabetic Men: Reversal with Testosterone.
    Eur J Endocrinol. 2018 Jan 16. pii: EJE-17-0673. doi: 10.1530/EJE-17-0673.
    PubMed     Abstract available


  84. QVIGSTAD E
    The diversity of gestational diabetes - a therapeutic challenge.
    Eur J Endocrinol. 2018 Jan 16. pii: EJE-18-0012. doi: 10.1530/EJE-18-0012.
    PubMed     Abstract available


    November 2017
  85. CHILOIRO S, De Marinis L
    Letter to the editor: Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.
    Eur J Endocrinol. 2017 Nov 15. pii: EJE-17-0910. doi: 10.1530/EJE-17-0910.
    PubMed     Abstract available


    October 2017
  86. GANTE I, Melo L, Dores J, Ruas L, et al
    Metformin in Gestational Diabetes Mellitus: predictors of poor response.
    Eur J Endocrinol. 2017 Oct 25. pii: EJE-17-0486. doi: 10.1530/EJE-17-0486.
    PubMed     Abstract available


  87. CHANTZICHRISTOS D, Persson A, Eliasson B, Miftaraj M, et al
    Incidence, prevalence, and seasonal onset variation of Addison's disease among persons with type 1 diabetes mellitus: nationwide, matched, cohort studies.
    Eur J Endocrinol. 2017 Oct 24. pii: EJE-17-0751. doi: 10.1530/EJE-17-0751.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: